Litcius/Paper detail

Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2

Kazem Abbaszadeh‐Goudarzi

2021Current Pharmaceutical Biotechnology13 citationsDOI

Abstract

Bentham Science - STM publisher of online and print journals, and related print/online book series. Bentham Science answers the information needs of scientists in the fields of pharmaceutical, biomedical, medical, engineering, technology, computer and social sciences.

Topics & Concepts

CRISPRCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPandemicVirologyComputational biologyMedicineBiologyInfectious disease (medical specialty)DiseaseGeneGeneticsOutbreakPathologySARS-CoV-2 and COVID-19 ResearchCRISPR and Genetic EngineeringSARS-CoV-2 detection and testing
Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2 | Litcius